Global Blood Therapeutics is categorized under Biotherapeutics in South San Francisco, CA and active since 2011.
Global Blood Therapeutics was established in 2011, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Biotherapeutics business, which does work in the BOTH market, and is classified as a Biotherapeutics, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Mark Goldsmith at the company’s single location by writing to 400 East Jamie Court # 101, South San Francisco, California CA 94080 or by phoning (650) 741-7700. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Global Blood Therapeutics |
| Contact Person: | Mark Goldsmith |
| Address: | 400 East Jamie Court # 101, South San Francisco, California 94080 |
| Phone Number: | (650) 741-7700 |
| Website Address: | globalbloodtx.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B & B2C |
| Business Category: | Biotherapeutics |
| SIC Code: | 5122 |
| NAICS Code: | 424210 |
| Share This Business: |
Global Blood Therapeutics was started in 2011 to provide professional Biotherapeutics under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Mark Goldsmith for inquiries that concern Global Blood Therapeutics by calling the company number (650) 741-7700, as your correspondence is most welcome. Additionally, the physical location of the single location of Global Blood Therapeutics can be found at the coordinates 37.649025,-122.387108 as well as the street address 400 East Jamie Court # 101 in South San Francisco, California 94080.
For its online presence, you may visit Global Blood Therapeutics’s website at globalbloodtx.com and engage with its social media outlets through on Twitter and on Facebook.